dimarts, 26 de març del 2019

FDA reviews requirements for nicotine replacement therapy product labels

Emergo GroupBy Stephanie Larson and Richard Featherstone, Emergo Group

Nicotine replacement therapy (NRT) drug products, such as patches, gum and lozenges, have been around for more than 30 years. More novel products such as e-cigarettes provide additional choices for people using NRT for smoking cessation. But, like any other drug delivery mechanism, there are risks as well as benefits when using NRT drug products. While the technology has been marching ahead, regulators have been taking an increased interest in how to manage the risks of harm associated with using such products.

Get the full story here at the Emergo Group’s blog.

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.

The post FDA reviews requirements for nicotine replacement therapy product labels appeared first on MassDevice.



from MassDevice https://ift.tt/2HROtjT

Cap comentari:

Publica un comentari a l'entrada